Abstract
The control of pore size and structure, drug release capacity, and biodegradation of scaffolds is of importance for bone tissue engineering. In this study, a technique combining polymer coagulation, cold compression molding, salt particulate leaching and drug coating method was developed to fabricate poly (ethylene glycol)/dexamethasone coated porous poly-d-l-lactide/nano-hydroxyapatite (PDLLA/nano-HAp) scaffolds. These scaffolds possess homogenous pore networks with high porosity (66-82%) and controllable pore size (200-300μm). The compressive moduli and strength of the scaffolds after incorporation of nano-HAp were improved by 50% and 20%, respectively. The surface hydrophilicity of the scaffold was significantly improved by poly (ethylene glycol)/dexamethasone coating and nano-HAp addition, leading to a higher initial drug loading amount. The results showed that the drug release behavior of the scaffolds after 35-day immersion in water could be adjusted by varying the porosity level and by incorporation of 20 wt% of nano-HAp.
Original language | English |
---|---|
Pages (from-to) | 1842-1849 |
Number of pages | 8 |
Journal | Composites Science and Technology |
Volume | 71 |
Issue number | 16 |
DOIs | |
Publication status | Published - 14 Nov 2011 |
Keywords
- B. Porosity/Voids
- B. Surface treatments
- E. Casting
ASJC Scopus subject areas
- Ceramics and Composites
- General Engineering